Marked rise in BP.
Adrenaline should not be given to patients receiving β blockers.
Source: KDT 7e · p133
Beta Blocker · Antihypertensive, Antiarrhythmic, Antianginal
Also known as Acebutolol hydrochloride
Acebutolol is a beta-adrenoceptor blocking drug that blocks beta-adrenoceptors in the heart, peripheral vasculature, bronchi, pancreas, and liver. It slows the heart and can depress the myocardium. Due to its intrinsic sympathomimetic activity, it tends to cause less bradycardia. In hypertension, it reduces cardiac output, alters baroreceptor reflex sensitivity, blocks peripheral adrenoceptors, and may depress plasma renin secretion.
Present in breast milk in greater amounts than other beta-blockers.
Marked rise in BP.
Adrenaline should not be given to patients receiving β blockers.
Source: KDT 7e · p133
Hyperkalaemia more likely.
Source: KDT 7e
Severe bradycardia.
Extreme caution advised if amiodarone is co-administered with sofosbuvir and a beta blocker.
Source: Harrison 22e · unknown
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Increased propensity for AV block, severe bradycardia, and decreased left ventricular function.
Avoid concurrent administration. The concurrent administration of diltiazem with a beta blocker is contraindicated.
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: antagonism
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-10 · House clinical team